ATE195120T1 - Verfahren zur herstellung von n-alkyl-n-pyridinyl-1h-indol-1-aminen - Google Patents

Verfahren zur herstellung von n-alkyl-n-pyridinyl-1h-indol-1-aminen

Info

Publication number
ATE195120T1
ATE195120T1 AT95106921T AT95106921T ATE195120T1 AT E195120 T1 ATE195120 T1 AT E195120T1 AT 95106921 T AT95106921 T AT 95106921T AT 95106921 T AT95106921 T AT 95106921T AT E195120 T1 ATE195120 T1 AT E195120T1
Authority
AT
Austria
Prior art keywords
sub
loweralkyl
hydrogen
pyridinyl
indole
Prior art date
Application number
AT95106921T
Other languages
English (en)
Inventor
Thomas Bing Kin Lee
Keith E Goehring
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Application granted granted Critical
Publication of ATE195120T1 publication Critical patent/ATE195120T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Indole Compounds (AREA)
AT95106921T 1994-05-13 1995-05-08 Verfahren zur herstellung von n-alkyl-n-pyridinyl-1h-indol-1-aminen ATE195120T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/242,395 US5459274A (en) 1994-05-13 1994-05-13 Preparation of N-alkyl-N-pyridinyl-1H-indol-1-amines

Publications (1)

Publication Number Publication Date
ATE195120T1 true ATE195120T1 (de) 2000-08-15

Family

ID=22914624

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95106921T ATE195120T1 (de) 1994-05-13 1995-05-08 Verfahren zur herstellung von n-alkyl-n-pyridinyl-1h-indol-1-aminen

Country Status (11)

Country Link
US (3) US5459274A (de)
EP (1) EP0683165B1 (de)
JP (1) JP3816968B2 (de)
AT (1) ATE195120T1 (de)
AU (1) AU697090B2 (de)
CA (1) CA2149286A1 (de)
DE (1) DE69518192T2 (de)
DK (1) DK0683165T3 (de)
ES (1) ES2152342T3 (de)
GR (1) GR3034751T3 (de)
PT (1) PT683165E (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3811885B2 (ja) * 1998-03-02 2006-08-23 塩野義製薬株式会社 ４−チアゾリルメチル誘導体の製造方法
TWI243164B (en) * 2001-02-13 2005-11-11 Aventis Pharma Gmbh Acylated indanyl amines and their use as pharmaceuticals
GB0119435D0 (en) * 2001-02-15 2001-10-03 Aventis Pharm Prod Inc Method of treating of demyelinating diseases or conditions
US20040082615A1 (en) * 2002-08-07 2004-04-29 Michael Konkel 3-Imino-2-indolones for the treatement of depression and/or anxiety
TW200410937A (en) * 2002-08-07 2004-07-01 Synaptic Pharma Corp 3-imino-2-indolones for the treatment of depression and/or anxiety
AR046041A1 (es) * 2003-10-03 2005-11-23 Aventis Pharma Inc Procedimiento para la preparacion de compuestos heterociclicos n-amino sustituidos
FR2892021B1 (fr) * 2005-10-19 2008-01-04 Urogene Traitement de l'incontinence urinaire d'effort et mixte
FR2892022B1 (fr) * 2005-10-19 2008-01-04 Urogene Sa Traitement des symptomes de l'irritation de la vessie
FR2897614B1 (fr) * 2006-02-20 2008-05-23 Urogene Forme cristalline du chlorhydrate de la besipirdine, procedes de preparation et utilisations

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1458633A (en) * 1974-09-17 1976-12-15 Ici Ltd Process for dehalogenating aromatic compounds
JPS5687635A (en) * 1979-12-15 1981-07-16 Yoshikawa Kogyo Kk Forming method for protective covering layer of lance dipped in molten metal
US4692554A (en) * 1983-10-18 1987-09-08 Mitsui Toatsu Chemicals, Inc. Process for producing 1,3-bis(3-aminophenoxy)benzene
US4618686A (en) * 1984-09-27 1986-10-21 Ciba-Geigy Corporation Process for dehalogenation of aryl and alpha-araliphatic halides
US5032599A (en) * 1986-11-12 1991-07-16 Hoechst-Roussel Pharmaceuticals Inc. N-(pyrrol-l-yl)pyridinamines
US4752610A (en) * 1985-12-04 1988-06-21 Hoechst-Roussel Pharmaceuticals Inc. N-(pyrrol-1-yl)pyridinamines having memory enhancing properties
US5039811A (en) * 1987-04-24 1991-08-13 Hoechst-Roussel Pharmaceuticals Inc. Preparation of N-(pyridinyl)-1H-indol-1-amines
US4880822A (en) * 1987-04-24 1989-11-14 Hoechst-Roussel Pharmaceuticals, Inc. N-(pyridinyl)-1H-indol-1-amines
DE3852335T2 (de) * 1987-04-24 1995-05-11 Hoechst Roussel Pharma N-(Pyridinyl)-1H-indol-1-amine, Verfahren zu deren Herstellung und ihre Verwendung als Arzneimittel.
US4970218A (en) * 1987-04-24 1990-11-13 Hoechst-Roussel Pharmaceuticals Inc. N-(pyridinyl)-1H-indol-1-amines
EP0415103B1 (de) * 1989-08-02 1995-02-01 Hoechst-Roussel Pharmaceuticals Incorporated 2,3-Dihydro-1-(pyridinylamino)-indole, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
US4983608A (en) * 1989-09-05 1991-01-08 Hoechst-Roussell Pharmaceuticals, Inc. N-substituted-4-pyrimidinamines and pyrimidinediamines
US5102891A (en) * 1990-07-23 1992-04-07 Hoechst-Roussel Pharmaceuticals Inc. 1-(substituted pyridinylamino)-1H-indol-5-yl substituted carbamates
US5319096A (en) * 1992-04-03 1994-06-07 Hoechst-Roussel Pharmaceuticals Inc. (1H-indol-1-yl)-2-(amino) acetamides and related (1H-indol-1-yl)-(aminoalkyl)amides, pharmaceutical composition and use
US5356910A (en) * 1993-07-19 1994-10-18 Hoechst-Roussel Pharmaceuticals Inc. Use of N-(pyridinyl)-1H-indol-1-amines for the treatment of obsessive-compulsive disorder

Also Published As

Publication number Publication date
DK0683165T3 (da) 2000-10-16
EP0683165A3 (de) 1997-01-15
AU697090B2 (en) 1998-09-24
DE69518192T2 (de) 2001-05-31
CA2149286A1 (en) 1995-11-14
EP0683165B1 (de) 2000-08-02
JPH07304768A (ja) 1995-11-21
US5644062A (en) 1997-07-01
GR3034751T3 (en) 2001-02-28
EP0683165A2 (de) 1995-11-22
JP3816968B2 (ja) 2006-08-30
US5459274A (en) 1995-10-17
ES2152342T3 (es) 2001-02-01
PT683165E (pt) 2000-12-29
US6512125B1 (en) 2003-01-28
AU1799795A (en) 1995-11-23
DE69518192D1 (de) 2000-09-07

Similar Documents

Publication Publication Date Title
DE69624695T2 (de) VERFAHREN ZUR SPEZIFISCHEN KOPPLUNG EINER SCHUTZGRUPPE AN DAS 5'-ENDE EINES mRNA-FRAGMENTES UND DIE HERSTELLUNG VON mRNA UND VOLLSTÄNDIGER cDNA
ATE242228T1 (de) Verfahren zur herstellung von gamma-butyrolacton sowie dessen verwendung
ATE195120T1 (de) Verfahren zur herstellung von n-alkyl-n-pyridinyl-1h-indol-1-aminen
ATE266030T1 (de) 1,4,7,10-tetraazabicyclo(8.2.2)tetradecan-2-on, verfahren zu ihrer herstellung und ihrer verwendung für die herstellung von tetraazamacrocyclen
ATE277915T1 (de) Verfahren sowie neue zwischenprodukte zur herstellung von isoxazolin-3-yl-acylbenzolen
ATE359272T1 (de) Verfahren zur herstellung von 3-hydroxy-n-1,6-
ATE169013T1 (de) Verfahren zur herstellung von gamma-butyrolacton
DE69414724D1 (de) Verfahren zur herstellung von zwischenprodukten zur synthese von antifungale mittel
DE60105441D1 (de) Verfahren zur herstellung von pantoprazol und zwischenprodukte dieses verfahrens
ATE299851T1 (de) Verfahren zur herstellung von zwischenprodukten
ATE270287T1 (de) 2,3-dihydro-1h-isoindolderivate, verfahren zu ihrer herstellung und ihre verwendung als hemmer der serotoninwiederaufnahme
DE69520947T2 (de) Diarinopropanole abgeleitet von aminosäuren
ATE244706T1 (de) Enantiomere von mercaptolactonen und verfahren zu ihrer herstellung
DE50003633D1 (de) Verfahren zur herstellung von l-ascorbinsäure
ATE233732T1 (de) Verfahren zur herstellung von azetidin-2- carbonsäure und zwischenprodukten davon
ATE213734T1 (de) Verfahren zur herstellung von 1,3- disubstituierten 2-nitroguanidinen
DE69608698D1 (de) Verfahren zur herstellung von optisch aktiven carbonsäuren
ATE237591T1 (de) Verbessertes verfahren zur herstellung von halo-4-phenoxychinolinen
ATE281444T1 (de) Verfahren zur herstellung von gamma-butyrolacton
ATE139765T1 (de) Verfahren zur herstellung von halogenanthranilsäuren
DE60229261D1 (de) Verfahren zur herstellung von säureanhydrid
ATE231159T1 (de) Neues verfahren zur herstellung von etoposid
ATE247618T1 (de) Verfahren zur herstellung von 1,4-diaryl-2-fluor- 1,3-butadien- und 1,4-diaryl-2-fluor-2- butenverbindungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner